
Piper Sandler has decided to maintain its Overweight rating of Amgen (NASDAQ:AMGN) and raise its price target from $255.00 to $260.00.
Shares of Amgen are trading down 5.5% over the last 24 hours, at $235.12 per share.

Piper Sandler has decided to maintain its Overweight rating of Amgen (NASDAQ:AMGN) and raise its price target from $255.00 to $260.00.
Shares of Amgen are trading down 5.5% over the last 24 hours, at $235.12 per share.